Author Correction: Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancer (Scientific Reports, (2019), 9, 1, (3931), 10.1038/s41598-019-40571-0)

Peng Chan Lin; Yu Min Yeh; Pei Ying Wu; Keng Fu Hsu; Jang Yang Chang; Meng Ru Shen

doi:10.1038/s41598-020-69145-1

Author Correction: Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancer (Scientific Reports, (2019), 9, 1, (3931), 10.1038/s41598-019-40571-0)

Peng Chan Lin, Yu Min Yeh, Pei Ying Wu, Keng Fu Hsu, Jang Yang Chang, Meng Ru Shen

Research output: Contribution to journal › Comment/debate › peer-review

2 Citations (Scopus)

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Original language	English
Article number	12216
Journal	Scientific Reports
Volume	10
Issue number	1
DOIs	https://doi.org/10.1038/s41598-020-69145-1
Publication status	Published - Dec 2020
Externally published	Yes

ASJC Scopus subject areas

General

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/s41598-020-69145-1

Fingerprint

Dive into the research topics of 'Author Correction: Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancer (Scientific Reports, (2019), 9, 1, (3931), 10.1038/s41598-019-40571-0)'. Together they form a unique fingerprint.

Cite this

Lin, P. C., Yeh, Y. M., Wu, P. Y., Hsu, K. F., Chang, J. Y., & Shen, M. R. (2020). Author Correction: Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancer (Scientific Reports, (2019), 9, 1, (3931), 10.1038/s41598-019-40571-0). Scientific Reports, 10(1), Article 12216. https://doi.org/10.1038/s41598-020-69145-1

Author Correction: Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancer (Scientific Reports, (2019), 9, 1, (3931), 10.1038/s41598-019-40571-0). / Lin, Peng Chan; Yeh, Yu Min; Wu, Pei Ying et al.
In: Scientific Reports, Vol. 10, No. 1, 12216, 12.2020.

Research output: Contribution to journal › Comment/debate › peer-review

@article{3662f1e7aa6f41b1babfe13905acfd73,

title = "Author Correction: Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancer (Scientific Reports, (2019), 9, 1, (3931), 10.1038/s41598-019-40571-0)",

abstract = "An amendment to this paper has been published and can be accessed via a link at the top of the paper.",

author = "Lin, {Peng Chan} and Yeh, {Yu Min} and Wu, {Pei Ying} and Hsu, {Keng Fu} and Chang, {Jang Yang} and Shen, {Meng Ru}",

note = "Publisher Copyright: {\textcopyright} 2020, The Author(s).",

year = "2020",

month = dec,

doi = "10.1038/s41598-020-69145-1",

language = "English",

volume = "10",

journal = "Scientific Reports",

issn = "2045-2322",

publisher = "Nature Research",

number = "1",

}

TY - JOUR

T1 - Author Correction

T2 - Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancer (Scientific Reports, (2019), 9, 1, (3931), 10.1038/s41598-019-40571-0)

AU - Lin, Peng Chan

AU - Yeh, Yu Min

AU - Wu, Pei Ying

AU - Hsu, Keng Fu

AU - Chang, Jang Yang

AU - Shen, Meng Ru

PY - 2020/12

Y1 - 2020/12

N2 - An amendment to this paper has been published and can be accessed via a link at the top of the paper.

AB - An amendment to this paper has been published and can be accessed via a link at the top of the paper.

UR - http://www.scopus.com/inward/record.url?scp=85088012792&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85088012792&partnerID=8YFLogxK

U2 - 10.1038/s41598-020-69145-1

DO - 10.1038/s41598-020-69145-1

M3 - Comment/debate

C2 - 32678259

AN - SCOPUS:85088012792

SN - 2045-2322

VL - 10

JO - Scientific Reports

JF - Scientific Reports

IS - 1

M1 - 12216

ER -

Author Correction: Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancer (Scientific Reports, (2019), 9, 1, (3931), 10.1038/s41598-019-40571-0)

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this